Ecthyma-gangrenosum-like bullous pemphigoid

Dermatology

Volumn 221, Issue 2, 2010, Pages 142-148

  Geiss Steiner, Jana ^a   Trüeb, Ralph M ^a   Kerl, Katrin ^a   Mühleisen, Beda ^a   French, Lars E ^a   Hofbauer, Günther F L ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Bullous pemphigoid; Ecthyma gangrenosum; Ecthymata

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEFEPIME; CIPROFLOXACIN; CORTICOSTEROID; DOXYCYCLINE; FLUCLOXACILLIN; MYCOPHENOLIC ACID; NICOTINAMIDE; STEROID;

AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BODY MASS; BULLOUS PEMPHIGOID; CASE REPORT; CONTAGIOUS ECTHYMA; ECTHYMA; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HISTOLOGY; HUMAN; IMMUNOFLUORESCENCE; MENTAL DISEASE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PYODERMA; RHEUMATIC DISEASE; SKIN BIOPSY; STAPHYLOCOCCUS AUREUS; VASCULITIS; WESTERN BLOTTING;

ADRENAL CORTEX HORMONES; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; AUTOANTIBODIES; AUTOANTIGENS; CHRONIC DISEASE; CIPROFLOXACIN; DERMATOLOGIC AGENTS; DOXYCYCLINE; ECTHYMA; FATAL OUTCOME; FEMALE; HUMANS; MYCOPHENOLIC ACID; NIACINAMIDE; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; TREATMENT OUTCOME;

EID: 77956343719     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000316098     Document Type: Article

References (33)

1. Jung M, Kippes W, Messer G, et al: Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 1999; 41: 266-268.
2. Korman N: Bullous pemphigoid. J Am Acad Dermatol 1987; 16: 907-924.
3. Zillikens D: Bullous pemphigoid: an autoimmune blistering disease of the elderly. J Geriatr Dermatol 1996: 35-41.
4. Zillikens D, Wever S, Roth A, et al: Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995; 131: 957-958.
5. Laffitte E, Borradori L: Bullous pemphigoid and related disorders; in Hertl M (ed): Autoimmune Diseases of the Skin. Wien, Springer, 2001.
6. Vaillant L, Bernard P, Joly P, et al: Evaluation of clinical criteria for diagnosis of bullous pemphigoid. French Bullous Study Group. Arch Dermatol 1998; 134: 1075-1080.
7. Joly P, Courville P, Lok C, et al: Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera. Dermatology 2004; 208: 16-20.
8. Giudice GJ, Emery DJ, Diaz LA: Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 1992; 99: 243-250.
9. Joly P, Benichou J, Lok C, et al: Prediction of survival for patients with bullous pemphigoid: a prospective study. Arch Dermatol 2005; 141: 691-698.
10. Tanaka M, Hashimoto T, Dykes PJ, et al: Clinical manifestations in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles. Clin Exp Dermatol 1996; 21: 23-27.
11. Thoma-Uszynski S, Uter W, Schwietzke S, et al: BP230- and BP180-specific auto-antibodies in bullous pemphigoid. J Invest Dermatol 2004; 122: 1413-1422.
12. Georgi M, Jainta S, Brocker EB, et al: Autoantigens of subepidermal bullous autoimmune dermatoses (in German). Hautarzt 2001; 52: 1079-1089.
13. Korman NJ: Bullous pemphigoid: the latest in diagnosis, prognosis, and therapy. Arch Dermatol 1998; 134: 1137-1141.
14. Mueller S, Klaus-Kovtun V, Stanley JR: A 230-kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol 1989; 92: 33-38.
15. Thoma-Uszynski S, Uter W, Schwietzke S, et al: Autoreactive T and B cells from bullous pemphigoid (BP) patients recognize epitopes clustered in distinct regions of BP180 and BP230. J Immunol 2006; 176: 2015-2023.
16. Skaria M, Jaunin F, Hunziker T, et al: IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230. J Invest Dermatol 2000; 114: 998-1004.
17. Hofmann S, Thoma-Uszynski S, Hunziker T, et al: Severity and phenotype of bullous pemphigoid relate to autoantibody profile against the NH 2 - and COOH-terminal regions of the BP180 ectodomain. J Invest Dermatol 2002; 119: 1065-1073.
18. Schmidt E, Obe K, Brocker EB, et al: Serum levels of autoantibodies to BP180 correlate with disease activity in patients with bullous pemphigoid. Arch Dermatol 2000; 136: 174-178.
19. Chan LS, Dorman MA, Agha A, et al: Pemphigoid vegetans represents a bullous pemphigoid variant: patient's IgG autoantibodies identify the major bullous pemphigoid antigen. J Am Acad Dermatol 1993; 28: 331-335.
20. Winkelmann RK, Su WP: Pemphigoid vegetans. Arch Dermatol 1979; 115: 446-448.
21. Bean SF, Michel B, Furey N, et al: Vesicular pemphigoid. Arch Dermatol 1976; 112: 1402-1404.
22. Saitoh A, Osada A, Ohtake N, et al: Erythrodermic bullous pemphigoid. J Am Acad Dermatol 1993; 28: 124-125.
23. Tappeiner G, Konrad K, Holubar K: Erythrodermic bullous pemphigoid: report of a case. J Am Acad Dermatol 1982; 6: 489-492.
24. Korman NJ, Woods SG: Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoid. Br J Dermatol 1995; 133: 967-971.
25. Borradori L, Prost C, Wolkenstein P, et al: Localized pretibial pemphigoid and pemphigoid nodularis. J Am Acad Dermatol 1992; 27: 863-867.
26. Hodzic-Avdagic N, Reinerth G, Reifenberger J, et al: Bullous pemphigoid: first manifestation under a picture of prurigo simplex subacuta (in German). Hautarzt 2007; 58: 290-292.
27. Powell AM, Albert S, Gratian MJ, et al: Pemphigoid nodularis (non-bullous): a clinicopathological study of five cases. Br J Dermatol 2002; 147: 343-349.
28. Wever S, Rank C, Hornschuh B, et al: Bullous pemphigoid simulating subacute simple prurigo (in German). Hautarzt 1995; 46: 789-795.
29. Madsen SM, Westh H, Danielsen L, et al: Bacterial colonization and healing of venous leg ulcers. APMIS 1996; 104: 895-899.
30. Bowler PG, Davies BJ: The microbiology of infected and noninfected leg ulcers. Int J Dermatol 1999; 38: 573-578.
31. Dinges MM, Orwin PM, Schlievert PM: Exotoxins of Staphylococcus aureus. Clin Microbiol Rev 2000; 13: 16-34.
32. Gjodsbol K, Christensen JJ, Karlsmark T, et al: Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 2006; 3: 225-231.
33. Wojnarowska F, Kirtschig G, Highet AS, et al: Guidelines for the management of bullous pemphigoid. Br J Dermatol 2002; 147: 214-221.